Kibow Biotech Selected to Present at the China Bio Partnering Forum 2010
Kibow Biotech, Inc. is pleased to announce that it has been selected as one of the six U.S.-based companies to present at the China Bio Partnering Forum to be held June 23-24, 2010, at Suzhou, China....
View ArticleInstitutional Review Board Approval Obtained for Study of Kibow(R) Biotics in...
On the occasion of World Kidney Day, Kibow Biotech, Inc. is pleased to announce its renewed commitment, hope and support for the worldwide maintenance of healthy kidney function among all those...
View ArticleKibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by...
Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health. The agreement...
View ArticleSomaGenics’ sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis...
SomaGenics, Inc., a biotechnology company specializing in RNA-based technologies, presented exciting data on the efficacy of RNA interference (RNAi) therapeutics against Hepatitis C virus (HCV) based...
View ArticleSomaGenics Announces Issue of Key Patent for Its sshRNA Technology and...
/PRNewswire/ – SomaGenics, Inc., a biotechnology company specializing in RNA-based technologies, has been awarded US Patent No. 8,283,460 for key aspects of the company’s sshRNA therapeutic platform....
View ArticleLife-and-Death Decision-Making: Patients at the Center of Clinical Trials
/PRNewswire/ – Clinical trials are the cornerstone of getting biopharmaceuticals approved to treat diseases now and develop new medicines and knowledge for the future. Many people are unfamiliar with...
View ArticleDelta Point Continues to Expand Management Capabilities with Addition of...
/PRNewswire/ – Cathy Geddes, former commercial leader at Pfizer, Wyeth and Roche, has recently joined Delta Point, Inc. as Senior Vice President with responsibility for leading the operations of the...
View ArticleGene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene...
/PRNewswire/ – Startup biotechnology company Neuralgene (http://neuralgene.com) has announced that it will begin animal studies in May to evaluate the efficacy of PRCN-829, its new gene therapy agent...
View ArticleMicrovi Biotechnologies Appoints Former COO of Zenon Environmental as...
/PRNewswire/ – Rafael Simon, a veteran in the environment and energy industries, has joined Microvi Biotechnologies as Chairman of its Board of Directors. Rafael was the COO of Zenon Environmental, a...
View Article
More Pages to Explore .....